Patents by Inventor Peter Noertersheuser

Peter Noertersheuser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140093516
    Abstract: The invention provides human antibodies that bind to the p40 subunit of human IL-12 and/or IL-23. The invention further provides a method of treating psoriasis in a subject by administering to a subject an antibody that binds to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: October 2, 2013
    Publication date: April 3, 2014
    Inventors: Matthew Hruska, Susan K. Paulson, Peter Noertersheuser, Sven Mensing, Walid Awni
  • Patent number: 8557239
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: October 15, 2013
    Assignees: AbbVie Inc., AbbVie Deutschland GmbH & Co. KG
    Inventors: Joaquin Mario Valdes, Elliot K. Chartash, William T. Barchuk, Susan K. Paulson, Kenneth B. Gordon, Walid M. Awni, Yanjun Bao, William G. Glass, Yihua Gu, Tom C. Harris, Martin Kaul, Parvez M. Mulani, Peter Noertersheuser, Martin M. Okun
  • Publication number: 20120225080
    Abstract: The invention provides human antibodies that bind to the p40 subunit of human IL-12 and/or IL-23. The invention further provides a method of treating psoriasis in a subject by administering to a subject an antibody that binds to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: January 13, 2012
    Publication date: September 6, 2012
    Applicant: Abbott Laboratories
    Inventors: Matthew W. Hruska, Susan K. Paulson, Walid Awni, Peter Noertersheuser, Sven Mensing
  • Publication number: 20110206680
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 14, 2010
    Publication date: August 25, 2011
    Applicants: ABBOTT LABORATORIES, ABBOTT GMBH & CO., KG
    Inventors: JOAQUIN MARIO VALDES, ELLIOT K. CHARTASH, WILLIAM T. BARCHUK, SUSAN K. PAULSON, KENNETH B. GORDON, WALID M. AWNI, YANJUN BAO, WILLIAM G. GLASS, YIHUA GU, TOM C. HARRIS, MARTIN KAUL, PARVEZ M. MULANI, PETER NOERTERSHEUSER, MARTIN M. OKUM
  • Publication number: 20080070917
    Abstract: The invention relates to a method of administering an inotropic agent (such as, but not limited to, a levosimendan compound) or a pharmaceutically acceptable salt thereof in the treatment of cardiovascular disorders.
    Type: Application
    Filed: April 27, 2007
    Publication date: March 20, 2008
    Inventors: Roopal Thakkar, Leticia Delgado-Herrera, Rajendra Pradhan, Peter Noertersheuser, Walid Awni, Wenhui Zhang